UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): ~~August~~February 2018, ~~2004~~2005 (~~August~~February 1217, ~~2004~~2005)

Advanced Neuromodulation Systems, Inc.

(Exact name of registrant as specified in its charter)


Texas	0-10521	75-1646002

(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

6901 Preston Road Plano, Texas 75024 (Address of principal executive offices) (Zip code)

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code:
(972) 309-8000

TABLE OF CONTENTS

	Item 2. “Acquisition or Disposition of Assets.”
	Item 8.01 “Other Events”.
	Item 9. “Regulation FD Disclosure.”
SIGNATURES
INDEX TO EXHIBITS
Press Release

Item 28.01 “~~Acquisition~~Other ~~or Disposition of Assets.~~Events”.

On ~~August~~February 1214, 15, 16 and 1317, ~~2004~~2005, weAdvanced ~~acquired~~Neuromodulation 3Systems, Inc.~~5 million~~ ~~shares~~(the “Company”), through orits ~~approximately 14~~wholly-owned subsidiary, SPAC Acquisition Corp.~~87%~~, sold all of the ~~outstanding~~3.5 million shares of the common stock of Cyberonics, Inc. ~~(NASDAQ:~~held ~~CYBX)~~by the Company. All 3.5 million shares were sold in ~~open~~ open market ~~purchases~~transactions. WeThe ~~purchased~~common ~~the~~stock ~~shares~~of atCyberonics, ~~prices~~Inc. ~~that~~had ~~ranged~~previously ~~between~~been acquired by the Company on ~~$13.74~~August 12 and ~~$14.52~~13, ~~per share~~2004. ~~The~~Gross ~~aggregate~~proceeds ~~cash~~from ~~purchase~~the ~~price~~sale ~~that~~were weapproximately ~~paid~~$135,290,000 ~~for~~and the ~~shares~~Company ~~was~~expects to have a pre-tax gain of approximately $4985,200,000.~~56 million.~~

OnTable August 19, 2004, our chief executive officer contacted Cyberonics’ chief executive officer to apprise him of our investment, and to invite Cyberonics to discuss, in general, the opportunities presented by a possible business combination of Advanced Neuromodulation Systems and Cyberonics. Contents

~~Item 9. “Regulation FD Disclosure.”~~SIGNATURES

On Pursuant ~~August 20,~~to ~~2004,~~the werequirements ~~issued~~of athe ~~press~~Securities ~~release~~Exchange ~~disclosing~~Act ~~the acquisition~~ of 1934, the ~~Cyberonics~~ ~~shares~~Registrant ~~and~~has ~~the~~duly caused ~~contact~~this ~~between~~report ~~our~~to ~~respective~~be ~~chief~~signed ~~executive officers.~~on Aits ~~copy~~behalf ofby the ~~press~~undersigned ~~release~~thereunto isduly ~~attached as Exhibit 99~~authorized.1.

~~This~~ Dated: ~~press release shall not be deemed “filed” for purposes of Section~~February 18 ~~of the Securities Exchange Act of 1934~~, ~~as amended (the “Exchange Act”), or~~2005 ~~otherwise incorporated by reference in any filing under the Securities Act of~~ ~~1933, as amended, or the Exchange Act.~~

~~Table~~ADVANCED ofNEUROMODULATION ~~Contents~~SYSTEMS, INC. By: /s/ F. Robert Merrill III Name: F. Robert Merrill III Title: Executive Vice President, Finance, Chief Financial Officer and Treasurer

SIGNATURES Table of Contents

~~Pursuant~~INDEX toTO ~~the requirements of the Securities Exchange Act of 1934, the~~EXHIBITS ~~Registrant has duly caused this report to be signed on its behalf by the~~ ~~undersigned thereunto duly authorized.~~

Dated: August 20, 2004


Exhibit
Number		Description
99.1		Press Release dated February 18, 2005 (This press release shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act)

ADVANCED NEUROMODULATION SYSTEMS, INC. By: /s/ F. Robert Merrill III Name: F. Robert Merrill III Title: Executive Vice President, Finance, Chief Financial Officer and Treasurer

INDEX TO EXHIBITS

Exhibit
Number		Description
99.1		Press Release dated August 20, 2004 (This press release shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act)

Filing Compare · ADVANCED NEUROMODULATION SYSTEMS INC